How Funding Stage Shapes the Health Tech Nurses Use & the Jobs They Take

You may have never considered the funding stage of a company or product you use, but you’ve almost certainly experienced the symptoms of funding decisions: 😒

•  A pilot program never matures

•  A tool that promises to solve a pain point but feels chaotic or unreliable. 

•  Being asked to do workarounds with the promise of “this will be automated later.”

The behavior of health tech isn’t random, it's financial.

Simply put, money dictates the speed, scope, and risk tolerance of a health tech startup. Funding introduces expectations, pressure, and competing priorities. Nurses often experience the downstream effects first.

Products built without sufficient capital (or without the right investment in people and infrastructure) often require clinicians to absorb the consequences.

That shows up as:

• Unstable systems

• Poorly designed workflows

• Incomplete features

• Manual workarounds

• Misaligned product priorities

Capital can help with any number of core traits of a successful company (stable infrastructure, clinically influenced workflow, targeted marketing and sales) but at the core of each of these traits is its people. Without adequate funding symptoms bubble up for end users which is ambiguous, until you start to understand what it means for a company's focus and resources.

There are generally 5 funding stages to be aware of:

Each of these funding stages shed light on the success of the company but it does not mean the company is without risk.

Take a look at a few examples:

Ambience Healthcare, now at the Series C stage (as of July 2025), has raised approximately $345 million. With reported high adoption rates, validated ROI, and strong market positioning, the company demonstrates how effective use of capital (combined with execution) can drive both product success and clinician adoption.

In contrast, Olive AI raised over $400 million between 2017 and 2021 but shut down in 2023. Leadership cited “fast-paced growth and lack of focus” as key challenges. Despite significant funding, misalignment in strategy and execution ultimately led to failure.

Funding alone doesn’t determine success but how that funding is deployed does.

If you’ve ever felt like you’re giving away free feedback to a company, you are. 😅

This is most common in earlier-stage companies, where rapid iteration depends heavily on clinician input.  In contrast, more mature companies tend to offer more stable (though sometimes more rigid) workflows as they execute on established infrastructure and capital.

Funding not only affects clinicians as an end user, but it shapes the job market as well. While funding enables hiring, it does not guarantee stability. If you’re a clinician considering a role in health tech, understanding a company’s funding stage should be part of your evaluation, not an afterthought.

💭 Questions you may want to ask:

• What is the funding stage?

• What are the primary goals tied to this funding round?

• If pre-seed or seed: what is the plan for future funding? What are the strategies that are employed to position the company well for funding?

• What is the company’s current market position?

• What are this year’s top company priorities?

Look for clarity and consistency in answers across interviewers, alignment is a strong signal of focus and leadership.

The work environment at a health tech startup is influenced by many factors.

Leadership, product quality, culture etc. For purposes of this article, we will focus on the influence of funding. Funding matters as an employee because you will experience the symptoms as the company navigates, market pressures, changing priorities, speed and workload.

1. 🌱 Pre-seed: This is the stage of proving the problem and building an MVP. It’s where ideas become real companies.

For clinicians, this means:

•  High influence

•  Low structure

• Significant ambiguity

Some will find this frustrating; others will find it energizing. Nurses who are comfortable with autonomy and ambiguity often thrive here. I had my first health tech start up experience at this stage. No job description, no KPIs, no SOPs. 

After a lot of tripping and falling, I learned to harness the power of autonomy. Each client interaction was inventing the wheel. Establishing processes was routine and underwent frequent iteration (image having no files in your file explorer). The result of invention and iteration was a product/process/system that I was very proud of.

A practical example: I had significant input on a new patient management application. I worked with a team of engineers to successfully migrate existing customers through a lot of trial and error. But a month or so later, we had a new client going live. I realized a few days before training, there was no user guide. It was on no one’s radar and with a team of ~20 people, someone needed to take the initiative. I ended up spending several weekend hours creating a 20 page user guide because I felt confident that as a clinician, I was best suited to create the guide. I didn’t get credit for this work or tell people other than to send the link to where it was saved. Taking initiative and the “see a need, fill a need” mindset was key to my success critically needed at pre-seed companies.

2. Series 🅰️: This is where things accelerate and often become chaotic. Many companies fail between Series A and Series B due to pressure to scale before the product is ready.

Clinicians in this stage:

• Wear multiple hats

• Translate between users, product, and sales

•  Perform “invisible” work critical to growth

This stage offers high influence but comes with real burnout risk. It’s not for everyone.

3. Series 🅱️: Companies shift toward stability, process, and scale. Roles become more defined, and expectations are clearer. However, funding at this stage does not eliminate risk and execution still matters. As seen with companies like Olive AI, even well-funded organizations can fail without alignment and focus.

4. 🌊 Series C+:  Series C+ companies offer structure, predictability, and relative stability. While opportunities for influence may be more limited, these organizations provide clearer roles, established processes, and lower day-to-day volatility.

If you’re reading this article, you don’t need convincing as to why clinicians (nurses specifically) are invaluable in health tech. But the funding stage of a company can dramatically shape your experience as both a user and an employee. If you prefer stability and structure, later-stage companies may be the right fit. If you thrive in ambiguity and want to help build from the ground up, early-stage startups may suit you. Understanding funding doesn’t turn nurses into investors, it turns them into informed participants in a system that impacts them every day.